Evidence map›Paper›PMID 32570774›Full record

ArticleInternational journal of molecular sciences2020

Biomarkers of Oxidative Stress and Inflammation in Chronic Airway Diseases.

Liliya Chamitava, Lucia Cazzoletti, Marcello Ferrari, Vanessa Garcia-Larsen, Aneza Jalil, Paolo Degan, Alessandro G Fois, Elisabetta Zinellu, Sara S Fois, Anna Maria Fratta Pasini and 6 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Research advance in correlation between childhood asthma and gut microbiota.Frontiers in cellular and infection microbiology · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. The Leucocyte Telomere Length,Current issues in molecular biology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Liliya ChamitavaUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
Lucia CazzolettiUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
Marcello FerrariUnit of Respiratory Medicine, Department of Medicine, University of Verona, 37134 Verona, Italy.
Vanessa Garcia-LarsenDepartment of International Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Aneza JalilPakistan Institute of Medical Sciences, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad 44000, Pakistan.
Paolo DeganU.O. Mutagenesi e Prevenzione Oncologica, Ospedale Policlinico San Martino, 16132 Genova, Italy.
Alessandro G FoisDepartment of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0001-5330-572X
Elisabetta ZinelluUnit of Respiratory Diseases, University Hospital Sassari (AOU), 07100 Sassari, Italy.
Sara S FoisDepartment of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.
Anna Maria Fratta PasiniDepartment of Medicine, Section of General Medicine and Atherothrombotic and Degenerative Diseases, University of Verona, 37134 Verona, Italy.ORCID 0000-0001-7661-7785
Morena NicolisUnit of Hygiene and Preventive, Environmental and Occupational Medicine, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
Mario OlivieriUnit of Occupational Medicine, Azienda Ospedaliero Universitaria di Verona, 37134 Verona, Italy.ORCID 0000-0001-6105-0376
Angelo CorsicoDivision of Respiratory Diseases, ERCS, S. Matteo, Hospital University of Pavia, 27100 Pavia, Italy.
Roberto BonoDepartment of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-2471-6594
Pietro PirinaDepartment of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0003-1457-8025
Maria Elisabetta ZanolinUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
University of Verona · ITUniversity of Sassari · ITAzienda Ospedaliera Universitaria Integrata Verona · ITJohns Hopkins University · USOspedale Policlinico San Martino · ITPakistan Institute of Medical Sciences · PKUniversity of Pavia · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe global burden of chronic airway diseases represents an important public health concern. The role of oxidative stress and inflammation in the pathogenesis of these diseases is well known. The aim of this study is to evaluate the behavior of both inflammatory and oxidative stress biomarkers in patients with chronic bronchitis, current asthma and past asthma in the frame of a population-based study.

methodsFor this purpose, data collected from the Gene Environment Interactions in Respiratory Diseases (GEIRD) Study, an Italian multicentre, multicase-control study, was evaluated. Cases and controls were identified through a two-stage screening process of individuals aged 20-65 years from the general population. Out of 16,569 subjects selected from the general population in the first stage of the survey, 2259 participated in the clinical evaluation. Oxidative stress biomarkers such as 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), 8-isoprostane and glutathione and inflammatory biomarkers such as Fractional Exhaled Nitric Oxide (FENO) and white blood cells were evaluated in 1878 subjects.

resultsCurrent asthmatics presented higher levels of FENO (23.05 ppm), leucocytes (6770 n/µL), basophils (30.75 n/µL) and eosinophils (177.80 n/µL), while subjects with chronic bronchitis showed higher levels of GSH (0.29 mg/mL) and lymphocytes (2101.6 n/µL). The multivariable multinomial logistic regression confirmed high levels of leucocytes (RRR = 1.33), basophils (RRR = 1.48), eosinophils (RRR = 2.39), lymphocytes (RRR = 1.26) and FENO (RRR = 1.42) in subjects with current asthma. Subjects with past asthma had a statistically significant higher level of eosinophils (RRR = 1.78) with respect to controls. Subjects with chronic bronchitis were characterized by increased levels of eosinophils (RRR = 2.15), lymphocytes (RRR = 1.58), GSH (RRR = 2.23) and 8-isoprostane (RRR = 1.23).

conclusionIn our study, current asthmatics show a greater expression of the inflammatory profile compared to subjects who have had asthma in the past and chronic bronchitis. On the other hand, chronic bronchitis subjects showed a higher rate of expression of oxidative stress biomarkers compared to asthmatic subjects. In particular, inflammatory markers such as circulating inflammatory cells and FENO seem to be more specific for current asthma, while oxidative stress biomarkers such as glutathione and 8-isoprostane appear to be more specific and applicable to patients with chronic bronchitis.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAdultAgedAsthmaBiomarkersBronchitis, ChronicCase-Control StudiesDinoprostFemaleGlutathioneHumansLeukocyte CountMaleMiddle AgedOxidative StressYoung Adult8-epi-prostaglandin F2alpha8-Hydroxy-2'-DeoxyguanosineBiomarkersDinoprostGlutathioneasthmachronic bronchitisinflammationoxidative stress

Identifiers

PMID32570774
PMCPMC7353047
OpenAlexW3035787046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.